Suppr超能文献

DNA初免和蛋白加强免疫引发的抗1型人类免疫缺陷病毒Env抗体的中和活性及亲和力研究

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting.

作者信息

Richmond J F, Lu S, Santoro J C, Weng J, Hu S L, Montefiori D C, Robinson H L

机构信息

Department of Pathology, University of Massachusetts School of Medicine, Worcester, Massachusetts, USA.

出版信息

J Virol. 1998 Nov;72(11):9092-100. doi: 10.1128/JVI.72.11.9092-9100.1998.

Abstract

DNA vaccination is an effective means of eliciting strong antibody responses to a number of viral antigens. However, DNA immunization alone has not generated persistent, high-titer antibody and neutralizing antibody responses to human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env). We have previously reported that DNA-primed anti-Env antibody responses can be augmented by boosting with Env-expressing recombinant vaccinia viruses. We report here that recombinant Env protein provides a more effective boost of DNA-initiated antibody responses. In rabbits primed with Env-expressing plasmids, protein boosting increased titer, persistence, neutralizing activity, and avidity of anti-Env responses. While titers increased rapidly after boosting, avidity and neutralizing activity matured more slowly over a 6-month period following protein boosting. DNA priming and protein immunization with HIV-1 HXB-2 Env elicited neutralizing antibody for T cell line-adapted, but not primary isolate, viruses. The most effective neutralizing antibody responses were observed after priming with plasmids which expressed noninfectious virus-like particles. In contrast to immunizations with HIV-1 Env, DNA immunizations with the influenza virus hemagglutinin glycoprotein did not require a protein boost to achieve high-titer antibody with good avidity and persistence.

摘要

DNA疫苗接种是引发针对多种病毒抗原的强烈抗体反应的有效手段。然而,单独的DNA免疫尚未产生针对人类免疫缺陷病毒1型(HIV-1)包膜糖蛋白(Env)的持续、高滴度抗体和中和抗体反应。我们之前报道过,用表达Env的重组痘苗病毒加强免疫可增强DNA引发的抗Env抗体反应。我们在此报告,重组Env蛋白能更有效地加强DNA引发的抗体反应。在用表达Env的质粒进行初免的兔子中,蛋白加强免疫提高了抗Env反应的滴度、持久性、中和活性和亲和力。加强免疫后滴度迅速升高,而亲和力和中和活性在蛋白加强免疫后的6个月内成熟得更慢。用HIV-1 HXB-2 Env进行DNA初免和蛋白免疫可引发针对T细胞系适应病毒而非原代分离病毒的中和抗体。在用表达无感染性病毒样颗粒的质粒进行初免后,观察到最有效的中和抗体反应。与用HIV-1 Env免疫不同,用流感病毒血凝素糖蛋白进行DNA免疫不需要蛋白加强免疫就能产生具有良好亲和力和持久性的高滴度抗体。

相似文献

引用本文的文献

7
One Group's Historical Reflections on DNA Vaccine Development.一组人对 DNA 疫苗开发的历史反思。
Hum Gene Ther. 2018 Sep;29(9):966-970. doi: 10.1089/hum.2018.066. Epub 2018 Aug 21.

本文引用的文献

6
Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques.
Vaccine. 1997 Jun;15(8):924-6. doi: 10.1016/s0264-410x(96)00271-x.
7
Early studies on DNA-based immunizations for measles virus.
Vaccine. 1997 Jun;15(8):888-91. doi: 10.1016/s0264-410x(96)00261-7.
8
Anti-HIV env immunities elicited by nucleic acid vaccines.核酸疫苗引发的抗HIV包膜免疫
Vaccine. 1997 Jun;15(8):884-7. doi: 10.1016/s0264-410x(96)00251-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验